Medline Inc
NASDAQ:MDLN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Medline Inc
NASDAQ:MDLN
|
US |
|
Bank Sinarmas Tbk PT
IDX:BSIM
|
ID |
|
Suncorp Group Ltd
ASX:SUN
|
AU |
|
K
|
Kwesst Micro Systems Inc
NASDAQ:KWE
|
CA |
|
Wipro Ltd
NYSE:WIT
|
IN |
|
Viva Leisure Ltd
ASX:VVA
|
AU |
|
Archer Materials Ltd
ASX:AXE
|
AU |
|
BankGuam Holding Co
OTC:BKGM
|
GU |
Medline Inc
Medline Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Northfield, Illinois. The company went IPO on 2025-12-17. Medline Inc. is a provider of medical-surgical products and supply chain solutions serving all points of care. The firm delivers mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities. The company operates through two segments: Medline Brand and Supply Chain Solutions. These segments offer approximately 335,000 medical-surgical products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. Its Medline Brand products are organized into three product categories: Front Line Care, Surgical Solutions, and Laboratory and Diagnostics. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands and also provides tailored logistics and supply chain optimization services to domestic and international consumers.
Medline Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Northfield, Illinois. The company went IPO on 2025-12-17. Medline Inc. is a provider of medical-surgical products and supply chain solutions serving all points of care. The firm delivers mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities. The company operates through two segments: Medline Brand and Supply Chain Solutions. These segments offer approximately 335,000 medical-surgical products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. Its Medline Brand products are organized into three product categories: Front Line Care, Surgical Solutions, and Laboratory and Diagnostics. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands and also provides tailored logistics and supply chain optimization services to domestic and international consumers.
Strong year: Medline said 2025 was a milestone year, with net sales of $28.4 billion, up 12%, and strong fourth-quarter momentum.
Tariff pressure: Tariffs remained a major headwind, but management said mitigation, sourcing changes, and a price increase helped offset part of the burden; 2026 still includes a $200 million tariff headwind.
Growth drivers: New customer signings were a major highlight, with $2.4 billion of total new signings in 2025, including major wins in VA, lab, and large integrated delivery networks.
2026 outlook: Medline guided to 8% to 9% organic sales growth and $3.5 billion to $3.6 billion of adjusted EBITDA, while saying utilization may soften a bit if reimbursement pressure worsens.
Balance sheet: The IPO strengthened liquidity, with $7 billion raised, $4 billion used to pay down debt, and net leverage falling to 3.1x.
Automation push: The company is expanding AutoStore and piloting Symbotic bulk-picking automation, aiming to improve speed, accuracy, and capacity across its distribution network.
